Biosergen AB (publ) (STO:BIOSGN)

Market Cap	99.10M -13.2%
Revenue (ttm)	2.09M
Net Income	-40.82M
EPS	-17.38
Shares Out	2.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	212
Average Volume	2,030
Open	42.20
Previous Close	42.20
Day's Range	42.20 - 42.20
52-Week Range	28.10 - 67.80
Beta	0.32
RSI	48.30
Earnings Date	Mar 31, 2026

About Biosergen AB

Biosergen AB (publ), a biotech company, develops antifungal products. Its lead product is BSG005, an antifungal drug candidate for the treatment of invasive fungal infections in immunocompromised patients, including AIDS, cancer, and transplant recipients. The company was founded in 2004 and is based in Solna, Sweden.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 1
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BIOSGN